Osimertinib is used to treat non-small cell lung cancer (NSCLC) that has a genetic mutation called epidermal growth factor receptor (EGFR).
Taking Osimertinib as instructed is essential for your treatment to be as effective as possible. Please keep the following points in mind:
If you need surgery, inform your doctor that you are taking Osimertinib, as it may need to be paused until your wound has healed following some procedures.
Common side effects occur in approximately one third of patients taking Osimertinib. However, please note that you may not experience these side effects.
Decreased white blood cells (WBCs) and increased risk of infection | A blood test will be done before each new cycle to monitor your WBC count, haemoglobin, platelet count, liver, and kidney function. |
Decreased haemoglobin (part of the red blood cells that carry iron and oxygen) | Take steps to avoid infection: wash hands frequently, especially before eating and after using the toilet. Avoid crowds and people with infections. |
Decreased platelet count and increased risk of bleeding | Avoid bruises, cuts, or burns. Blow your nose gently and avoid picking it. Brush your teeth gently with a soft toothbrush. Use an electric razor instead of a blade when shaving. |
Changes in kidney function | Contact us if you notice reduced urination, swelling of legs or feet. |
Infections:
Fatigue:
Low Haemoglobin:
Low Platelets:
Diarrhoea:
Rash or Itchy Skin:
If your rash worsens or itching persists, contact your doctor.
Osimertinib remains in your body for several days after taking it, so traces of the drug may be present in urine, stool, sweat, or vomit. To keep yourself, your loved ones, and the environment safe, follow these precautions:
Compiled by: Karin Mouton
Registered Oncology Nurse
Disclaimer
This e-brochure has been auto-translated for your convenience. While machine translations are helpful, they may contain errors. Medinformer is actively working to have all translations reviewed by professional, mother-tongue language speakers, though this process will take time. For the most accurate information, please refer to the original English version. Medinformer and its partners cannot be held responsible for any inaccuracies that may result from the translation.
Thank you for your understanding.